SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 24.83 |
| Enterprise Value ($M) | 24.29 |
| Book Value ($M) | 9.58 |
| Book Value / Share | 0.31 |
| Price / Book | 2.59 |
| NCAV ($M) | 4.41 |
| NCAV / Share | 0.14 |
| Price / NCAV | 5.64 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.35 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -0.95 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.80 |
| Current Ratio | 1.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 13.18 |
| Assets | 18.35 |
| Liabilities | 8.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2.03 |
| Operating Income | -18.46 |
| Net Income | -7.87 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -19.09 |
| Cash from Investing | 18.04 |
| Cash from Financing | -16.35 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ingalls & Snyder Llc | 8.50 | 4.84 | |
| 13G/A | Asen R Scott | 9.92 | 17.94 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 32,924 | 139,458 | 23.61 | |
| 14,074 | 60,607 | 23.22 | |
| 38,007 | 76,023 | 49.99 | |
| 11,809 | 94,236 | 12.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DMAC – DiaMedica Therapeutics Inc. | DNTH – Dianthus Therapeutics, Inc. |
| DRMA – Dermata Therapeutics, Inc. | DRUG – Bright Minds Biosciences Inc. |
| DTIL – Precision BioSciences, Inc. |
Financial data and stock pages provided by
Fintel.io